Skip to main content
. 2018 May 17;176(8):1051–1058. doi: 10.1111/bph.14327

Table 2.

PG analogue‐containing fixed‐dose combination product evaluated in clinical trials

PG analogue Other ocular hypotensive (Class) Phase Trial number at www.clinicaltrials.gov website
Bimatoprost Brimonidine (α adrenoceptor agonist)) 2 NCT01863953
Travoprost Brinzolamide (carbonic anhydrase inhibitor) 3 NCT00767494
Travoprost AR‐12286 (rho kinase inhibitor) 2 NCT01789736
Latanoprost Dorzolamide (carbonic anhydrase inhibitor) 2 NCT01896180